Company: CYTK
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001140361-25-013167
Chunk: 55

Company: CYTOKINETICS INC
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 55
---
) of Regulation S-K as an individual who served as the Company’s principal financial officer during the last completed fiscal year. Mr. Jaw left the Company in February 2024. Mr. Pletcher resigned his employment in March 2025. Overview of Compensation Program We design our executive compensation program to provide a competitive compensation package that focuses on corporate and individual performance, a balance of short and long-term results, while maximizing retention. The highlights of our 2024 executive compensation program include:

| • | a merit salary increase of 4% to our named executive officers and other employees (with exceptions on a case-by-case basis); |

| • | an annual cash payment under our non-equity incentive plan (“NEIP”) designed to reward individuals for achieving corporate goals and, except for our CEO, individual goals in their functional area; and |

| • | stock options, restricted stock units (“RSUs”), and performance stock units (“PSUs”) to our named executive officers to incentivize our named executive officers to achieve multi-year strategic goals, to deliver sustained long-term value to stockholders, and to reward them for doing so. |

We have a standing policy to hold an advisory vote on executive compensation every year. At our 2024 annual meeting of stockholders, approximately 96% of the shares voted in favor of our advisory proposal on executive compensation. The Compensation Committee believes this vote affirms our stockholders’ support for our compensation practices. Nevertheless, our Compensation Committee took steps to preemptively adopt changes in policies to align with practices that are increasingly expected by stockholders, including the granting of equity awards based on target values in dollars as opposed to fixed nominal unit awards.

| Cytokinetics, Inc.|2025 Proxy Statement |     | 39 |

TABLE OF CONTENTS Executive Compensation

We have implemented many compensation best practices, as follows:

| ✔ WHAT WE DO |     |                                                                                                                                                                                                                                                                                                                                                                                                    |     | ✘ WHAT WE DON’T DO |     |                                                                                                                                                                                                                                                                                                                                                                                        |
| ✔            |     | Maintain an Independent Compensation and Talent Committee. Our Compensation and Talent Committee consists solely of independent directors, and there were no compensation interlocks in fiscal year 2024.                                                                                                                                                                                          |     | ✘                  |     | No Executive Retirement Plans. We do not offer pension arrangements or retirement plans to our executive officers that are different from or in addition to those offered to our other employees.                                                                                                                                                                                      |
| ✔            |     | Retain an Independent Compensation Advisor. The Compensation and Talent Committee